Persisting Visual Hallucinations and Illusions in Previously Drug-Addicted Patients
The DOI matches its Crossref record.
Abstract
BACKGROUND: Tetrahydrocannabinol (cannabis) and lysergic acid diethylamide (LSD) are psychomimetic agents that induce impairment of sensory perception. Illusions and hallucinations are mostly visual. Most frequently the visual phenomena occur in conjunction with drug abuse. PATIENTS AND METHODS: Three previously drug-addicted patients were examined for either persisting or spontaneously recurrent visual phenomena. Two patients complained of persisting visual illusions (vibrations, dyskinetopsia and impaired depth perception) during more than 12 months after an excessive use of cannabis. The third patient was a multiple drug abuser (LSD for 6 years) and complained of visual hallucinations and palinopsia following heavy ethanol intake, 20 years after stopping the use of any drug. RESULTS: Results from neuro-ophthalmic and neurological examinations were normal for the first two patients. The third patient presented abnormal visual fields with preserved visual acuity; electroencephalography was abnormal, suggesting an underlying toxic encephalopathy. CONCLUSIONS: Persistent visual illusions or hallucinations can occur during several months after an intake of cannabis. Flash-back phenomena are frequent amongst LSD abusers. They rarely occur at long times after the last intake (20 years in the present case); when they do so, precipitating factors are often present (ethanol, medication, anesthesia). Such phenomena reflect the cortical dysfunctions that can be induced by illegal substances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M., Lorusso, M., Di Giannantonio, M., & Lerner, A. (2018) · Brain Sciences · doi:10.3390/brainsci8030047 · Cited by 171
“In a single case of HPPD symptoms and electroencephalographic (EEG) abnormalities, compatible with toxic encephalopathy, the visual hallucinations that recurred at any alcohol ingestion improved, but did not disappear with the use of Valproic Acid (1500 mg/day) [46].”
BackgroundInfluentialOrsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00240 · Cited by 99
“However, HPPD has also been reported following the consumption of all substances with hallucinogenic properties which possess pharmacological and clinical effects resembling those experienced with LSD by serotoninergic 5-HT2A (42), such as cannabis (18, 43, 44), 3,4-methylenedioxymethamphetamine (MDMA, aka “ecstasy”)…”
BackgroundHallucinogenic persisting perception disorder: a case series and review of the literature.
Ford, H., Fraser, C. L., Solly, E., Clough, M., Fielding, J., White, O., & Van Der Walt, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.878609 · Cited by 28
“Currently, the DSM-5 defines HPPD as occurring in the context of previous Frontiers in Neurology | www.frontiersin.org 5 May 2022 | Volume 13 | Article 878609 TABLE 5 | Continued Author Drug use Symptoms Investigations Treatment Recovery Lerner (31) LSD, natural THC, cocaine, MDMA Altered motion perception, color enha…”
BackgroundInfluentialPharmacological Treatment of Hallucinogen Persisting Perception Disorder (HPPD): A Systematic Review
Neven, A., & Blom, J. D. (2025) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000439 · Cited by 4
Metadata
- Authors
- Gaillard, M.-C., & Borruat, F.-X.
- Venue
- Klinische Monatsblätter für Augenheilkunde
- Publisher
- Georg Thieme Verlag KG
- Published
- 2003-03
- Volume
- 220
- Issue
- 3
- Pages
- 176-178
- ISSN
- 0023-2165 (ISSN-L)
- 1439-3999
- OpenAlex
- W2056619031
- Cited by
- 30
- References
- 0
- FWCI
- 0.16
- Type
- journal article
- Language
- de
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Persisting Visual Hallucinations and Illusions in Previously Drug-Addicted Patients. https://app.cochat.ai/papers/10.1055/s-2003-38173
- The paper
- Gaillard, M.-C., & Borruat, F.-X. (2003). Persisting Visual Hallucinations and Illusions in Previously Drug-Addicted Patients. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/s-2003-38173
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.